Breakpoints cover image

#128 – IDWeek 2025 Recap

Breakpoints

00:00

REVIST: S‑Trimani Avibactam versus Meropenem

Julie reviews REVISIT trial comparing s-trianam‑avibactam to meropenem for IAI and HAP/VAP; enrollment limited for MBL isolates.

Play episode from 55:58
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app